Abstract:BackgroundHypoxia-inducible factor 2 alpha (HIF2α), prolyl hydroxylase domain protein 2 (PHD2), and the von Hippel Lindau tumor suppressor protein (pVHL) are three principal proteins in the oxygen-sensing pathway. Under normoxic conditions, a conserved proline in HIF2α is hydroxylated by PHD2 in an oxygen-dependent manner, and then pVHL binds and promotes the degradation of HIF2α. However, the crystal structure of the HIF2α-pVHL complex has not yet been established, and this has limited research on the interaction between HIF and pVHL. Here, we constructed a structural model of a 23-residue HIF2α peptide (528–550)-pVHL-ElonginB-ElonginC complex by using homology modeling and molecular dynamics simulations. We also applied these methods to HIF2α mutants (HYP531PRO, F540L, A530 V, A530T, and G537R) to reveal structural defects that explain how these mutations weaken the interaction with pVHL.MethodsHomology modeling and molecular dynamics simulations were used to construct a three-dimensional (3D) structural model of the HIF2α-VHL complex. Subsequently, MolProbity, an active validation tool, was used to analyze the reliability of the model. Molecular mechanics energies combined with the generalized Born and surface area continuum solvation (MM-GBSA) and solvated interaction energy (SIE) methods were used to calculate the binding free energy between HIF2a and pVHL, and the stability of the simulation system was evaluated by using root mean square deviation (RMSD) analysis. We also determined the secondary structure of the system by using the definition of secondary structure of proteins (DSSP) algorithm. Finally, we investigated the structural significance of specific point mutations known to have clinical implications.ResultsWe established a reliable structural model of the HIF2α-pVHL complex, which is similar to the crystal structure of HIF1α in 1LQB. Furthermore, we compared the structural model of the HIF2α-pVHL complex and the HIF2α (HYP531P, F540L, A530V, A530T, and G537R)-pVHL mutants on the basis of RMSD, DSSP, binding free energy, and hydrogen bonding. The experimental data indicate that the stability of the structural model of the HIF2α-pVHL complex is higher than that of the mutants, consistently with clinical observations.ConclusionsThe structural model of the HIF2α-pVHL complex presented in this study enhances understanding of how HIF2α is captured by pVHL. Moreover, the important contact amino acids that we identified may be useful in the development of drugs to treat HIF2a-related diseases.

Homology Modeling and Molecular Dynamics Simulation of the HIF2α Degradation-Related HIF2α-VHL Complex.

QSAR Modeling and in Silico Design of Small-Molecule Inhibitors Targeting the Interaction Between E3 Ligase VHL and HIF-1$$\alpha $$Α

An efficient strategy for digging protein-protein interactions for rational drug design - A case study with HIF-1α/VHL

Inhibition Mechanism of Hydroxyproline-Like Small Inhibitors to Disorder HIF-VHL Interaction by Molecular Dynamic Simulations and Binding Free Energy Calculations

A Novel HIF2A Mutation Causes Dyslipidemia and Promotes Hepatic Lipid Accumulation

Proline Hydroxylation at Different Sites in Hypoxia-Inducible Factor 1α Modulates Its Interactions with the Von Hippel–Lindau Tumor Suppressor Protein

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Microtubular Stability Affects Pvhl-Mediated Regulation of HIF-1alpha Via the P38/mapk Pathway in Hypoxic Cardiomyocytes.

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

Analysis of the binding mode of a novel HIF1α inhibitor through molecular modelling.

Modeling the dynamics of hypoxia inducible factor-1α (HIF-1α) within single cells and 3D cell culture systems

A small molecule VHL molecular glue degrader for cysteine dioxygenase 1

Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2

Hypoxia inducible factor (HIF)-1 and -2:structure,function,and regulation

RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect

VHL Ser65 Mutations Enhance HIF2α Signaling and Promote Epithelial-Mesenchymal Transition of Renal Cancer Cells

Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma.

Exploring the inhibition mechanism on HIF-2 by inhibitor PT2399 and 0X3 using molecular dynamics simulations.

Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy

Hypoxia Inactivates the VHL Tumor Suppressor Through PIASy-mediated SUMO Modification.